Key facts
- This page summarizes Michael Bonner's Form 4 filing for CUMBERLAND PHARMACEUTICALS INC (CPIX).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jun 2021, 17:07.
Michael Bonner - 17 Mar 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CPIX
- Reported as of
- 17 Mar 2021
- Net transaction value
- -$24,661
- Reporting owner signature
- Michael Bonner
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Michael Bonner filed Form 4 for CUMBERLAND PHARMACEUTICALS INC (CPIX) on 11 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$24,661.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPIX
transaction
Common Stock
Tax liability
- Transaction value
- $3,436
- Shares
- -1,067
- Change %
- -5.3%
- Price
- $3.22
- Shares after
- 19,220
- Date
- 17 Mar 2021
- Ownership
- Direct
- Footnotes
- F1
CPIX
transaction
Common Stock
Other
- Transaction value
- $21,225
- Shares
- -7,500
- Change %
- -39%
- Price
- $2.83
- Shares after
- 11,720
- Date
- 17 May 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPIX
transaction
Derivative
Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +5,000
- Change %
- Price
- $0.000000
- Shares after
- 5,000
- Date
- 17 Mar 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $3.22
- Footnotes
- F3
CPIX
transaction
Derivative
Options (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $3.22
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Michael Bonner is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares.
Footnote F2
Resigned position as Chief Financial Officer effective May 17, 2021. All unvested equity awards forfeited upon resignation.
Footnote F3
100% vesting on March 17, 2025.